Status:
COMPLETED
Predicting the Outcome After Treatment of Meniscal Tears
Lead Sponsor:
Onze Lieve Vrouwe Gasthuis
Collaborating Sponsors:
University of New South Wales
Mayo Clinic
Conditions:
Meniscus Lesion
Surveys and Questionnaires
Eligibility:
All Genders
45-70 years
Brief Summary
In this study the investigators examined the ability of orthopaedic surgeons to predict the outcome of surgery and non-operative treatment in patients (age 45 to 70) with a non-obstructive meniscal te...
Detailed Description
The additional benefits of Arthroscopic Partial Meniscectomy (APM) in middle aged patients with a non-obstructive meniscal tear are under scrutiny for years. Despite the most recent publications recom...
Eligibility Criteria
Inclusion
- In this survey the investigators invited orthopaedic surgeons and residents from both the Netherlands and Australia to complete a meniscus survey, including a random sample of patients from the Escape trial. The in-/exclusion criteria are listed below.
- Patients between 45 and 70 years of age at presentation.
- A meniscal tear visualized on MRI. The meniscal tear can either be isolated or combined with a partial asymptomatic Anterior Cruciate Ligament (ACL) injury or an asymptomatic degenerative ACL shown on MRI with no abnormal clinical findings (a negative Lachman test and Pivot Shift).
- Mental Competence.
- Willingness to comply with follow up schedule.
- Written informed consent.
Exclusion
- Knee locking or trauma leading to acute surgery.
- One of the following associated injuries on the index knee:
- A symptomatic partial ACL rupture or any total ACL rupture determined by clinical examination (positive Lachman test and/or positive Pivot Shift) and shown on MRI;
- A complete Posterior Cruciate Ligament (PCL) injury;
- Cartilage change down to bone; grade 4 of the Kellgren Lawrence Grading Scale for Osteoarthritis visualized on X-ray;
- An injury to the lateral/posterolateral ligament complex with significantly increased laxity.
- A history of knee surgery other than diagnostic arthroscopy on the index knee.
- Tumors on MRI suspected for a malignancy.
- Obese patients with Body Mass Index (BMI) \> 35.
- ASA 4-5 patients which can severely interfere with rehabilitation.
- General disease that effects physical function or systemic medication/abuse of steroids (e.g., rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, gout, pseudogout)
- Any other medical condition or treatment interfering with the completion or assessment of the trial, e.g. contraindications to MRI or surgery.
- Drugs or alcohol abuse.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT03462134
Start Date
January 1 2018
End Date
January 1 2020
Last Update
February 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Onze Lieve Vrouwe Gasthuis
Amsterdam, North Holland, Netherlands, 1090 HM